AN2 TherapeuticsANTX
那斯達克 · USD
1.06
0.00
(0.00%)
收盤 08/02 02:32 (UTC+8)
盤後
0
0
(0%)
08/02 02:32 (UTC+8)
AN2 TherapeuticsANTX
1.06
0.00
(0.00%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 11,537 | - | - | - | - | 18,815 | 18,180 | 16,601 | 16,039 | 12,476 |
研發費用 | 7,690 | 5,397 | 8,287 | 12,149 | 14,655 | 14,919 | 14,429 | 13,538 | 11,985 | 8,752 |
推銷及管理費用 | 3,847 | 3,210 | 3,484 | 3,731 | 3,641 | 3,896 | 3,751 | 3,063 | 4,054 | 3,724 |
非經常性項目費用 | - | -9 | 2,243 | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -11,537 | -8,598 | -14,014 | -15,880 | -18,296 | -18,815 | -18,180 | -16,601 | -16,039 | -12,476 |
其他收入及費用 | 888 | 1,076 | 1,267 | 1,445 | 1,679 | 1,917 | 1,473 | 797 | 716 | 634 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -10,649 | -7,522 | -12,747 | -14,435 | -16,617 | -16,898 | -16,707 | -15,804 | -15,323 | -11,842 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -10,649 | -7,522 | -12,747 | -14,435 | -16,617 | -16,898 | -16,707 | -15,804 | -15,323 | -11,842 |
基本每股稅後盈餘(元) | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.79 | -0.61 |
稀釋每股稅後盈餘(元) | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.52 | -0.62 | -0.81 | -0.79 | -0.58 |
基本平均股數(千股) | 30053.00 | 29882.00 | 29841.00 | 29824.00 | 29763.00 | 29735.00 | 25645.00 | 19497.00 | 19385.00 | 19352.00 |
稀釋平均股數(千股) | 30053.00 | 29882.00 | 29841.00 | 29824.00 | 29763.00 | 29735.00 | 25645.00 | 19497.00 | 19385.00 | 19352.00 |
還原基本每股稅後盈餘(元) | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.79 | -0.61 |
還原稀釋每股稅後盈餘(元) | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.52 | -0.62 | -0.81 | -0.79 | -0.58 |
還原基本平均股數(千股) | 30,053 | 29,882 | 29,841 | 29,824 | 29,763 | 29,735 | 25,645 | 19,497 | 19,385 | 19,352 |
還原稀釋平均股數(千股) | 30,053 | 29,882 | 29,841 | 29,824 | 29,763 | 29,735 | 25,645 | 19,497 | 19,385 | 19,352 |
EBITDA(千元) | -11,092 | -8,089 | -13,478 | -15,325 | -17,708 | -18,204 | -17,360 | -16,265 | -15,758 | -12,217 |